Clinical Trial Update: Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) [Phase 2]

View source ↗

Summary

Phase 2 trial of a cytomegalovirus vaccine for donors and recipients undergoing allogeneic hematopoietic cell transplantation has completed, evaluating its use …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Syndrome
• Myelogenous Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• ASP0113 CMV vaccine (cytomegalovirus vaccine)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED